SAKK - Young oncologist academy — Was junge Onkologen von ESMO - EHA und ESTRO berichten
Highlights in Multiple myeloma
Final analysis of the MASTER trial: MRD-driven Daratumumab-KRd therapy in newly diagnosed MM patients Dr. Costa presented the final analysis of the phase 2 MASTER trial (1)